The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer
GIRAFE II期临床试验基于MVCT的“每日治疗体积”和“每日剂量”，旨在探讨何时以及如何对局部晚期头颈癌实施自适应放射治疗。
期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2019.02.006
Esteyrie, Vincent; Gleyzolle, Baptiste; Lusque, Amélie; Graff, Pierre; Modesto, Anouchka; Rives, Michel; Lapeyre, Michel; Desrousseaux, Jacques; Graulières, Eliane; Hangard, Gregory; Arnaud, François-Xavier; Ferrand, Regis; Delord, Jean-Pierre; Poublanc, Muriel; Mounier, Muriel; Filleron, Thomas; Laprie, Anne
